Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.036 AUD | -23.40% |
|
-25.00% | -62.89% |
Jun. 19 | Biotron's HIV Therapy Meets Primary Endpoints in Phase Two Trial; Shares Rally 15% | MT |
Apr. 05 | Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-62.89% | 28.15M | |
+16.20% | 122B | |
+21.53% | 116B | |
+22.18% | 27.03B | |
-21.84% | 20.36B | |
-16.89% | 16.43B | |
-18.06% | 15.91B | |
-44.74% | 15.6B | |
+61.56% | 14.94B | |
+3.18% | 13.59B |
- Stock Market
- Equities
- BIT Stock
- News Biotron Limited
- Biotron Starts Human Trials of COVID-19 Antiviral Drug; Shares Jump 13%